Table 1

Patient- and tumor characteristics
Characteristics No of patients (%)
All patients 401 (100)
Age
Median (range) 58 (29–91)
< 50 years 80 (20)
≥ 50 years 321 (80)
Mode of detection
Screening detected 167 (42)
Clinical signs 232 (58)
Unknown 2
Tumor size
≤ 20mm 263 (66)
> 20mm 136 (34)
Unknown 2
Node status
N0 233 (60)
N+ 157 (40)
Unknown 11
NHG
1 77 (20)
2 221 (56)
3 94 (24)
Unknown 9
ER status
Positive 312 (80)
Negative 77 (20)
Unknown 12
PR status
Positive 242 (62)
Negative 147 (38)
Unknown 12
Surgery breast
Mastectomy 157 (39)
Breast concerving surgery 243 (61)
Unknown 1
Surgery axilla
Axillary dissection 247 (63)
Sentinel node biopsy 142 (37)
No Surgery (incl in clinical trial) 12

Adjuvant treatment

No adjuvant treatment

137 (34)
Only Chemotherapy 65 (16)
Only Endocrine therapy 197 (49)
Missing 2
Radiotherapy
Breast 198 (49)
Locoregional lymph nodes 35 (9)
Breast + locoregional 39 (10)

Abbreviations: N0= node negative, N+= node positive, NHG= Nottingham histological grade, ER= oestrogen receptor, PR= progesterone receptor.

Falck et al.

Falck et al. BMC Cancer 2012 12:403   doi:10.1186/1471-2407-12-403

Open Data